SLS reports Thursday, Mar 18, 2027, after the close. After the last 4 reports the stock moved −2.1%, +6.5%, −8.5%, −2.0% the next day.
SLS is expected to report on Thursday, Mar 18, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 12, 2026 | -0.05 | -0.05 | −2.1% | +85.1% |
| Aug 11, 2026 | -0.04 | — | +6.5% | +18.6% |
| Mar 19, 2026 | -0.06 | -0.05 | −8.5% | −4.8% |
| Nov 12, 2025 | -0.08 | -0.06 | −2.0% | +2.0% |
| Aug 12, 2025 | -0.08 | -0.07 | −3.7% | +5.6% |
| May 13, 2025 | -0.11 | -0.07 | +7.1% | +37.6% |
| Mar 20, 2025 | -0.11 | -0.08 | −0.8% | −4.1% |
| Nov 13, 2024 | -0.13 | -0.10 | — | — |
Average move the next trading day over the last 7 reports: ±4.4% (2 of 7 up).
SLS is in an uptrend, momentum firm. $14 is the level overhead; $13 the first support below.
SLS at $13.66. Nearest resistance $14.00 (+2.5%). Nearest support $13.00 (−4.8%).
SLS chart, levels and analysis · Latest analysis: SELLAS Life Sciences Group (SLS) stock analysis, November 20, 2026: Strong upside bias despite recent pull‑back · Earnings this week
SLS is expected to report on Thursday, Mar 18, 2027, after the close.
SLS reports after the close, US Eastern time.
After its report on Nov 12, 2026, SLS moved −2.1% the next trading day.
Over the last 7 reports, SLS moved 4.4% on average the next trading day, up 2 times out of 7.
Updated Nov 13, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.